fff,smg l?t)- fle5mg
---o--. 5 mg ----c- l0 mg +20 mg Cmu 6c/mL) 10mg 20mg (mean t SD)
(nglml)
ft! omm fij /mm lfi o.tg e
triz [h] N-12 (23.0) (27.e) (2.00-6.00) I E 2 El AUC",""") C**,,, t*,,,0) trn,""
+Flt to mg 1 E zel
X nsrn NoaLevo@ o.75^e v;f) tvtzl-vlvffi rbfl:
375pg AUCo-real," (pg'hr/ml)
9Omg
,, 1) Psoriasis Area and severity Index
=3 r>w
1.16") 1.150, 0.6gol 0.5d),,'-,i7972ts) l.0l ") 0.97") 0.900,r1)7e'"'lt>2) 1.40d) 4lre-f'/"-tvta) 1.03') N) 717tt)-- 0.95f) 1.08") 1.21') 1.00s) 0.25mC/E (n:37) 0.5mC/E (n:36) lme/e(n=37) l 2
oxoethyubenzoic acid
l0 mg 40 mg ilv /mm fi! /mm ifi! Ymm fi! Jmm fi! 3mm f! 4mm
tl/2 (hr)
+4mg +8mg c*., (no/ml \
Gt/nL\ AUC r,." c."r.,. zmg & National Institute of Neurological and Communicative Disorders anq Stroke-Alzheimer's Disease and Related Disorders Association Mini-Mental State Examination Alzheimer's Disease Assessment Soale Japan - cognitive subscale Clinician' s InteryierBased lmpression of Change-plus oaregiver input Jaoan AUC. AUC-